NTRA

The liquid biopsy market is experiencing significant growth, driven by advancements in technology and increasing demand for non-invasive diagnostic methods. North America is the largest market, with a 48.11% share in 2023. Key drivers include increased benefits over conventional biopsy, rising cance...

Cathie Wood's Ark Invest has been making some interesting stock purchases, including Amazon, Tempus AI, and Natera. While Amazon and Tempus AI were bought at a discount, Natera faces some legal challenges that raise concerns.

This report analyzes the global market for laboratory-developed tests (LDTs), including the impact of new FDA regulations introduced in 2024. It covers the LDT services market and the market for LDT products sold to clinical laboratories, with a focus on key segments like infectious disease and onco...

Natera's President and Chief Business Officer, John Fesko, has sold a portion of his company shares worth over $57,000 to meet tax obligations related to the vesting of restricted stock units. The transaction reflects changes in insider ownership of the company's stock.